These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22641790)

  • 1. The FLU-FOBT Program in community clinics: durable benefits of a randomized controlled trial.
    Walsh JM; Gildengorin G; Green LW; Jenkins J; Potter MB
    Health Educ Res; 2012 Oct; 27(5):886-94. PubMed ID: 22641790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Offering annual fecal occult blood tests at annual flu shot clinics increases colorectal cancer screening rates.
    Potter MB; Phengrasamy L; Hudes ES; McPhee SJ; Walsh JM
    Ann Fam Med; 2009; 7(1):17-23. PubMed ID: 19139445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of the FLU-FOBT program in primary care a randomized trial.
    Potter MB; Walsh JM; Yu TM; Gildengorin G; Green LW; McPhee SJ
    Am J Prev Med; 2011 Jul; 41(1):9-16. PubMed ID: 21665058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and reach of the FLU-FIT program in an integrated health care system: a multisite randomized trial.
    Potter MB; Ackerson LM; Gomez V; Walsh JM; Green LW; Levin TR; Somkin CP
    Am J Public Health; 2013 Jun; 103(6):1128-33. PubMed ID: 23597357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The FLU-FIT program: an effective colorectal cancer screening program for high volume flu shot clinics.
    Potter MB; Somkin CP; Ackerson LM; Gomez V; Dao T; Horberg MA; Walsh J ME
    Am J Manag Care; 2011; 17(8):577-83. PubMed ID: 21851145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness of two pharmacy-based colorectal cancer screening interventions during an annual influenza vaccination campaign.
    Potter MB; Gildengorin G; Wang Y; Wu M; Kroon L
    J Am Pharm Assoc (2003); 2010 Mar-Apr 1; 50(2):181-7. PubMed ID: 20199960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptation of the FLU-FOBT Program for a primary care clinic serving a low-income Chinese American community: new evidence of effectiveness.
    Potter MB; Yu TM; Gildengorin G; Yu AY; Chan K; McPhee SJ; Green LW; Walsh JM
    J Health Care Poor Underserved; 2011 Feb; 22(1):284-95. PubMed ID: 21317522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
    Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
    J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of a randomized controlled trial to assess the comparative effectiveness of a multifaceted intervention to improve adherence to colorectal cancer screening among patients cared for in a community health center.
    Baker DW; Brown T; Buchanan DR; Weil J; Cameron KA; Ranalli L; Ferreira MR; Stephens Q; Balsley K; Goldman SN; Wolf MS
    BMC Health Serv Res; 2013 Apr; 13():153. PubMed ID: 23627550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An observational study of workflows to support fecal testing for colorectal cancer screening in primary care practices serving Medicaid enrollees.
    Mojica CM; Gunn R; Pham R; Miech EJ; Romer A; Renfro S; Clark KD; Davis MM
    BMC Cancer; 2022 Jan; 22(1):106. PubMed ID: 35078444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial.
    Baker DW; Brown T; Buchanan DR; Weil J; Balsley K; Ranalli L; Lee JY; Cameron KA; Ferreira MR; Stephens Q; Goldman SN; Rademaker A; Wolf MS
    JAMA Intern Med; 2014 Aug; 174(8):1235-41. PubMed ID: 24934845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial.
    Green BB; Anderson ML; Chubak J; Fuller S; Meenan RT; Vernon SW
    Cancer; 2016 Jan; 122(2):312-21. PubMed ID: 26488332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
    Todorov K; Wilson C; Sharplin G; Corsini N
    Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychological distress after a positive fecal occult blood test result among members of an integrated healthcare delivery system.
    Laing SS; Bogart A; Chubak J; Fuller S; Green BB
    Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):154-9. PubMed ID: 24220914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does access to a colorectal cancer screening website and/or a nurse-managed telephone help line provided to patients by their family physician increase fecal occult blood test uptake?: A pragmatic cluster randomized controlled trial study protocol.
    Clouston K; Katz A; Martens PJ; Sisler J; Turner D; Lobchuk M; McClement S;
    BMC Cancer; 2012 May; 12():182. PubMed ID: 22607726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Program to improve colorectal cancer screening in a low-income, racially diverse population: a randomized controlled trial.
    Jean-Jacques M; Kaleba EO; Gatta JL; Gracia G; Ryan ER; Choucair BN
    Ann Fam Med; 2012; 10(5):412-7. PubMed ID: 22966104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of test kit provision, and individual and family education on the uptake rates of fecal occult blood test in an Asian population: a randomized controlled trial.
    Ha TC; Yong SK; Yeoh KW; Kamberakis K; Yeo RM; Koh GC
    Cancer Causes Control; 2014 Nov; 25(11):1473-88. PubMed ID: 25088807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interval colorectal cancer rates after Hemoccult Sensa and survival by detection mode for individuals diagnosed with colorectal cancer in Winnipeg, Manitoba.
    Decker KM; Nugent Z; Lambert P; Biswanger N; Singh H
    PLoS One; 2018; 13(9):e0203321. PubMed ID: 30180176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to repeat fecal occult blood testing in an urban community health center network.
    Liss DT; Petit-Homme A; Feinglass J; Buchanan DR; Baker DW
    J Community Health; 2013 Oct; 38(5):829-33. PubMed ID: 23546555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.